Skip to main content

Engineers Gate Manager LP

SEC CIK
0001620220
Latest filing
Aug 14, 2026

DNLI holding history

Denali Therapeutics Inc. in every 13F filed by Engineers Gate Manager LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNLI overviewAll 13F holders of DNLIFull Q2 2026 holdings

Shares (Q2 2026)
57,430
Value
$1.48M
% of portfolio
<0.1%
Quarters held
17
Since Q1 2021
Holdings of DNLI by Engineers Gate Manager LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202657,430$1.48M<0.1%+41,320+256.5%AddedHolders
Q1 202616,110$309.3K<0.1%+16,110NewHolders
Q4 20250$00.0%−69,216−100.0%Sold outHolders
Q3 202569,216$1.01M<0.1%−46,885−40.4%ReducedHolders
Q2 2025116,101$1.62M<0.1%+98,903+575.1%AddedHolders
Q1 202517,198$233.8K<0.1%−36,160−67.8%ReducedHolders
Q4 202453,358$1.09M<0.1%+53,358NewHolders
Q3 20240$00.0%−11,130−100.0%Sold outHolders
Q2 202411,130$258.4K<0.1%−20,226−64.5%ReducedHolders
Q1 202431,356$643.4K<0.1%+18,684+147.4%AddedHolders
Q4 202312,672$271.9K<0.1%−10,937−46.3%ReducedHolders
Q3 202323,609$487.1K<0.1%−8,211−25.8%ReducedHolders
Q2 202331,820$939.0K<0.1%−24,965−44.0%ReducedHolders
Q1 202356,785$1.31M0.1%+56,785NewHolders
Q3 20220$00.0%−17,320−100.0%Sold outHolders
Q2 202217,320$510.0K<0.1%+1,274+7.9%AddedHolders
Q1 202216,046$516.0K<0.1%+10,356+182.0%AddedHolders
Q4 20215,690$254.0K<0.1%+5,690NewHolders
Q3 20210$00.0%−6,030−100.0%Sold outHolders
Q2 20216,030$473.0K<0.1%−8,550−58.6%ReducedHolders
Q1 202114,580$833.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.